BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8350619)

  • 1. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
    Janssen JW; Ludwig WD; Sterry W; Bartram CR
    Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test.
    van der Burg M; Smit B; Brinkhof B; Barendregt BH; Verschuren MC; Dib M; Beverloo HB; van Dongen JJ; Langerak AW
    Leukemia; 2002 Apr; 16(4):755-61. PubMed ID: 11960364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
    Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
    Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAL1 expression does not occur in the majority of T-ALL blasts.
    Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
    Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.
    Breit TM; Wolvers-Tettero IL; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 1991 Dec; 5(12):1076-86. PubMed ID: 1837811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
    Breit TM; Wolvers-Tettero IL; van Dongen JJ
    Oncogene; 1994 Jul; 9(7):1847-53. PubMed ID: 8208530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
    Curry JD; Smith MT
    Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene.
    Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A
    Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
    Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
    J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
    Meissner B; Bartram T; Eckert C; Trka J; Panzer-Grümayer R; Hermanova I; Ellinghaus E; Franke A; Möricke A; Schrauder A; Teigler-Schlegel A; Dörge P; von Stackelberg A; Basso G; Bartram CR; Kirschner-Schwabe R; Bornhäuser B; Bourquin JP; Cazzaniga G; Hauer J; Attarbaschi A; Izraeli S; Zaliova M; Cario G; Zimmermann M; Avigad S; Sokalska-Duhme M; Metzler M; Schrappe M; Koehler R; Te Kronnie G; Stanulla M
    Hum Mol Genet; 2014 Feb; 23(3):590-601. PubMed ID: 24045615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
    van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R
    Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Junctional sequences of T cell receptor V delta 2-D delta 3 or D delta 2-D delta 3 rearrangements in acute lymphoblastic leukemia].
    Kuang S; Dong S; Gu L
    Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):532-6, 574. PubMed ID: 8556543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
    Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
    Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
    Sudhakar N; Nancy NK; Rajalekshmy KR; Ramanan G; Rajkumar T
    Am J Hematol; 2007 Mar; 82(3):215-21. PubMed ID: 17133429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of T-cell receptor transcripts in a human T-cell leukemia bearing a t(1;14) and an inv(7); cell surface expression of a TCR-beta chain in the absence of alpha chain.
    Bernard O; Groettrup M; Mugneret F; Berger R; Azogui O
    Leukemia; 1993 Oct; 7(10):1645-53. PubMed ID: 8412327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.